Business
Can I Try Shrooms, Mom? – How to Talk to Your Kids about Psychedelics
Psychedelics are going mainstream, so how should you talk about them to your kids?
The time of psychedelics has come. There’s no denying that psychedelic drugs, especially magic mushrooms, are already mainstream.
This means that just like marijuana, it’s more easily accessible than ever despite the fact that it isn’t as widely legal as pot. But it can certainly get there in the near future.
It could get into the hands of underage kids, which is why it’s up to parents to educate children on the use of psychedelics. The risk for kids accidentally being exposed to psychedelics is also largely because more parents are microdosing mushrooms and other psychedelic drugs – after all, we need to heal ourselves too. Teenagers may also be experimenting with mushrooms in place of marijuana or alcohol. While mushrooms are safer choices, it’s still not
However, this also means we are ushering into a new era of parenting. It isn’t far off for mushrooms to be as common as wine soon, so how prepared are today’s parents to deal with it?
Just Say No: Not The Way To Go
Several decades ago, the DARE (Drug Abuse Resistance Education) Program launched the Just Say No campaign under Nancy Reagan. It was a simple education tactic, though one that is criticized to be far TOO simplistic in their approach towards drugs. The Just Say No campaign featured shady characters posing as drug dealers and users, basically moral failure, which meant to threaten kids by giving them the message that they could turn out to be losers if they used drugs, at all.
Needless to say, that tactic failed. Big time.
Millions of kids who were exposed to the campaign still ended up taking drugs.
Parents, don’t use the same approach. These days, you have successful people microdosing mushrooms and taking LSD. Many of them don’t have much dysfunction in their lives because psychedelics helps them cope, and even perform better at work. It’s considered normal – as normal as drinking alcohol – among adults. And there are many of us who can responsibly use psychedelics without any of the issues that the DARE program threatened us with. In addition, the Just Say No campaign did nothing else but spread misinformation and ignorance on drugs.
Kids who were exposed to Just Say No eventually realized that they were misled. As a result, they questioned everything and wanted to try it – without the proper guidance.
What parents need to do is provide children with key information and resources that they can use to make the right decisions when faced with the possibility of using psychedelics.
What To Tell Your Kids
Drugs is a blanket term to refer to a huge array of psychedelics, plant medicines, and hallucinogens. One of the biggest mistakes you can make is to generalize the effects of drugs.
That said, it’s also important to carefully reflect exactly what your perception and beliefs are surrounding psychedelics. Do you have any hard and fast rules, or are you more flexible? Are you open to your kid experimenting (safely) with psychedelics, or do you personally believe they should stay away from it?
If you think your child should stay away from psychedelics completely, that is your prerogative and it must be respected. Keep in mind though, that parents who bring up drug use in a way that’s similar to health problems have more success keeping their kids off drugs, than simply shaming them or threatening them about becoming a societal failure because of it.
On the other hand, if you are flexible and allowing your child to experiment albeit responsibly, here are some things to keep in mind:
- Provide detailed information and context: Drugs will have different effects on people. Marijuana may make some alert while it can make others sleepy, psychedelics can cause hallucinogens, a spiritual experience, or sheer laughter, and ecstasy can be risky but beneficial when taken under the guidance of someone who’s more experienced.
These are just a fraction of a myriad of ways psychedelics and drugs can affect people after consumption. Altered mental states will vary from one person to another, and make it clear that taking too much can definitely increase any health and safety risk as well as the chances that the experience will be unpleasant. Educate them on the benefits of starting slow and taking low doses especially at first.
- Pay special attention to children who may have congenital conditions or health problems: While psychedelics can certainly heal and help treat many conditions, these can be dangerous when consumed by a person who has existing health problems such as heart disease or other ailments. Teach your kids that sneaking out to experiment with psychedelics is not a wise choice at any age because of a condition they may have, while stressing the fact that drugs can interrupt their treatment and put them in harm’s way.
- Be open and transparent: If you have tried psychedelics yourself, share your experience. Parents who are open to drugs tend to have more transparent relationships with their children regarding drug use because they don’t fear being open to you, since you are open with them as well. Share both the good and bad experiences that you felt, and if you aren’t opposed to it, tell them that you are willing to support healthy drug experimentation when they are OF AGE. There’s no use turning to horror stories and alarming, falsified reports; drugs can benefit your kids when they get older the way it did with you.
Conclusion
There’s a big possibility that kids right now will at some point be exposed to the opportunity of taking psychedelics. Parents should be prepared with a helpful, informative discussion that will help their children make the right decisions moving forward, learning from the mistakes caused by the Just Say No program. With these tips in mind, you can strengthen your bond with your child despite the mainstream presence of psychedelics.
Source: https://cannabis.net/blog/medical/can-i-try-shrooms-mom-how-to-talk-to-your-kids-about-psychedelics
New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.
The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.
Golden Roots operates the The Cannabis Revolution Dispensary.
The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.
The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.
Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.
After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.
In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.
The company requested a hearing, which the regulator scheduled for Sept. 1.
At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.
Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.
Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.
The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:
- Regulators alleged in August that Albuquerque dispensary Sawmill Sweet Leaf sold out-of-state products and didn’t have a license for extraction.
- Paradise Exotics Distro lost its license in July after regulators alleged the company sold products made in California.
Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.
Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/
Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.
According to the complaint, filed Thursday in U.S. District Court in Massachusetts, retailer Canna Provisions, Treevit delivery service CEO Gyasi Sellers, cultivator Wiseacre Farm and MSO Verano Holdings Corp. are all harmed by “the federal government’s unconstitutional ban on cultivating, manufacturing, distributing, or possessing intrastate marijuana.”
Verano is headquartered in Chicago but has operations in Massachusetts; the other three operators are based in Massachusetts.
The lawsuit seeks a ruling that the “Controlled Substances Act is unconstitutional as applied to the intrastate cultivation, manufacture, possession, and distribution of marijuana pursuant to state law.”
The companies want the case to go before the U.S. Supreme Court.
They hired prominent law firm Boies Schiller Flexner to represent them.
The New York-based firm’s principal is David Boies, whose former clients include Microsoft, former presidential candidate Al Gore and Elizabeth Holmes’ disgraced startup Theranos.
Similar challenges to the federal Controlled Substances Act (CSA) have failed.
One such challenge led to a landmark Supreme Court decision in 2005.
In Gonzalez vs. Raich, the highest court in the United States ruled in a 6-3 decision that the commerce clause of the U.S. Constitution gave Congress the power to outlaw marijuana federally, even though state laws allow the cultivation and sale of cannabis.
In the 18 years since that ruling, 23 states and the District of Columbia have legalized adult-use marijuana and the federal government has allowed a multibillion-dollar cannabis industry to thrive.
Since both Congress and the U.S. Department of Justice, currently headed by Garland, have declined to intervene in state-licensed marijuana markets, the key facts that led to the Supreme Court’s 2005 ruling “no longer apply,” Boies said in a statement Thursday.
“The Supreme Court has since made clear that the federal government lacks the authority to regulate purely intrastate commerce,” Boies said.
“Moreover, the facts on which those precedents are based are no longer true.”
Verano President Darren Weiss said in a statement the company is “prepared to bring this case all the way to the Supreme Court in order to align federal law with how Congress has acted for years.”
While the Biden administration’s push to reschedule marijuana would help solve marijuana operators’ federal tax woes, neither rescheduling nor modest Congressional reforms such as the SAFER Banking Act “solve the fundamental issue,” Weiss added.
“The application of the CSA to lawful state-run cannabis business is an unconstitutional overreach on state sovereignty that has led to decades of harm, failed businesses, lost jobs, and unsafe working conditions.”
Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.
The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).
Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.
Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.
That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.
Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.
Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.
A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.
Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/
New Mexico cannabis operator fined, loses license for alleged BioTrack fraud
Marijuana companies suing US attorney general in federal prohibition challenge
Alabama to make another attempt Dec. 1 to award medical cannabis licenses
Pot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
New Mexico cannabis operator fined, loses license for alleged BioTrack fraud
Alabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business1 year agoPot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
-
Business1 year agoNew Mexico cannabis operator fined, loses license for alleged BioTrack fraud
-
Business1 year agoAlabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business1 year agoWashington State Pays Out $9.4 Million in Refunds Relating to Drug Convictions
-
Business1 year agoMarijuana companies suing US attorney general in federal prohibition challenge
-
Business1 year agoLegal Marijuana Handed A Nothing Burger From NY State
-
Business1 year agoCan Cannabis Help Seasonal Depression
-
Blogs1 year agoCannabis Art Is Flourishing On Etsy